South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine

Nov.13.2025
South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine
South Korea’s amendment to the Tobacco Business Act, which would classify synthetic nicotine vapes and vape liquids as “tobacco” for regulatory and taxation purposes, has been delayed once again. Despite the government stressing its urgency due to youth access and risks of illicit drug mixing, both ruling and opposition parties at the Legislation and Judiciary Committee meeting agreed that the bill requires further discussion.

Key Points

 

  • The bill would include synthetic nicotine vapes and vape liquids within the legal definition of “tobacco.”
  • Lawmakers agreed to delay the bill due to concerns over side effects and stockpiling risks.
  • Rep. Kim Ki-pyo (김기표) warned that a six-month grace period could enable bulk stockpiling to evade regulation.
  • Rep. Na Kyung-won (나경원) argued that nicotine analogues and drug-mixed liquids would remain unregulated under the current definition.
  • Deputy Prime Minister Koo Yun-cheol (구윤철) urged swift enactment, but Committee Chair Choo Mi-ae (추미애) requested government measures for nicotine analogues first.

 


 

2Firsts, November 12, 2025 — According to Asia Today, South Korea’s amendment to the Tobacco Business Act, which seeks to regulate synthetic nicotine and vape liquids, has once again been delayed. Although the government has repeatedly stressed the urgency of the legislation, the National Assembly’s Legislation and Judiciary Committee decided on the 12th to defer the bill, with both ruling and opposition lawmakers calling for further review.

 

The amendment would redefine synthetic nicotine vapes circulating on the market as “tobacco,” thereby subjecting them to regulation and taxation. Currently, vape liquids face virtually no oversight, raising long-standing concerns regarding youth access and the risk of drug-mixed liquids, which has prompted strong calls from the government for swift legislation.

 

Previously, the bill faced delays due to opposition from certain vape industry groups citing insufficient evidence and potential harm to small retailers. After research commissioned by the Ministry of Health and Welfare showed that synthetic nicotine contains significant harmful substances, discussions had accelerated since last year. Still, lawmakers expressed concern over unintended consequences following implementation.

 

Rep. Kim Ki-pyo (김기표) of the Democratic Party stated that if the law takes effect six months after promulgation, the gap would allow businesses to stockpile products to evade regulation. He argued that the bill should be held longer for further consideration.

 

Rep. Na Kyung-won (나경원) of the People Power Party added that because the definition of tobacco hinges on nicotine content, products containing nicotine analogues or narcotic substances would remain difficult to regulate. She suggested amending the definition and basing enforcement on the “point of sale.”

 

Deputy Prime Minister and Finance Minister Koo Yun-cheol (구윤철) responded that concerns were thoroughly discussed in the Strategy and Finance Committee and stressed that regulation of synthetic nicotine must be included, urging rapid implementation.

 

However, Committee Chair Choo Mi-ae (추미애) stated that deliberations would resume only after the government prepares countermeasures for nicotine analogues, highlighting the growing concern of their spread.

 

Image source: Asia Daily

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
Philip Morris Japan (PMJ) announced that it will open “IQOS Flagship Ginza” in Tokyo on September 4, 2026. The location will become the first global flagship space for PMI’s IQOS brand. PMJ said the venue will target adult smokers aged 20 and above and combine product experiences, community engagement and local cultural elements. The design will incorporate Japanese natural aesthetics and traditional craftsmanship. The launch reflects PMI’s broader strategy of strengthening consumer engagement through experiential retail and brand spaces. The existing IQOS Store Ginza is scheduled to close on August 30, 2026.
Jul.21
Product | Summo 150K Introduces Refillable Design With Up to 150,000 Puffs, Exploring a New High-Capacity Vape Format
Product | Summo 150K Introduces Refillable Design With Up to 150,000 Puffs, Exploring a New High-Capacity Vape Format
Summo has introduced the Summo 150K Refillable Disposable Vape, entering the ultra-high-puff vape segment with a claimed capacity of up to 150,000 puffs. The device combines a 40ml dual e-liquid system, transparent tank design, dual mesh coils and a 900mAh rechargeable battery, using a refillable structure to differentiate itself from conventional disposable vapes. The product appeared on overseas online retail channels including Vapesourcing and VapeBarTime between late June and early July 2026.
Jul.22
BAT Calls for Retailer Input in Future Nicotine Regulations
BAT Calls for Retailer Input in Future Nicotine Regulations
British American Tobacco (BAT) has called for stronger retailer involvement in shaping future nicotine product regulations in the UK, arguing that frontline market feedback should be considered during policy development. BAT said retailers provide direct insight into consumer behavior, market changes and regulatory implementation challenges. The comments come as the UK nicotine market undergoes regulatory changes, including the disposable vape ban, Vaping Products Duty and efforts to address illicit vape sales.
Jul.29
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
Kumulus Vape, Europe’s first publicly listed vape company, reported a 7.8% year-on-year decline in first-half 2026 revenue. Amid changing conditions in France’s vape market, the company said channel diversification helped offset pressure, with physical store sales increasing 41.5% year on year. Listed on Euronext Access Paris in 2019 and later transferred to Euronext Growth Paris, Kumulus Vape is viewed as a representative company of Europe’s vape sector. Its performance highlights the industry’s shift from rapid expansion toward more operationally focused growth.
Jul.27
Australia’s Tobacco Tax Debate Intensifies as One Nation’s Barnaby Joyce Warns of Illicit Market Growth
Australia’s Tobacco Tax Debate Intensifies as One Nation’s Barnaby Joyce Warns of Illicit Market Growth
Australian One Nation MP Barnaby Joyce has criticised continued tobacco excise increases, arguing that higher taxes are driving consumers toward illicit tobacco markets and benefiting organised crime groups.
Regulations
Jul.13 by 2Firsts Perspectives
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05